Home/Filings/4/0001213900-22-003333
4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-22-003333

CIK 0001728328other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:18 PM ET

Size

7.7 KB

Accession

0001213900-22-003333

Insider Transaction Report

Form 4
Period: 2022-01-24
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2022-01-2460,606411,818 total
    Exercise: $2.10From: 2016-05-16Exp: 2022-01-24Common shares (60,606 underlying)
Footnotes (2)
  • [F1]Converted from the Canadian dollar exercise price of C$2.64 using an exchange rate of C$1.2554 = $US1.00
  • [F2]Converted from the Canadian dollar exercise price of C$3.63 using an exchange rate of C$1.2554 = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817882

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:18 PM ET
Size
7.7 KB